Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

Two AI models have achieved gold medal standard for the first time in a prestigious competition for young mathematicians – ...

The "acqui-hire" strategy is on fire in this battle among tech titans seeking AI dominance and a Goliath just beat David ...

Co-founded by Elon Musk in 2016, Neuralink’s ‘patient one,’ Noland Arbaugh, received the first Brain Chip Implant (BCI) in ...

Neuralink achieved two brain transplants in a day, targeting 20 by year-end. CEO Elon Musk envisions healing paralysis and ...

Chicago, IL – July 17, 2025– Today, Zacks Investment Ideas feature highlights Alphabet GOOGL, Meta Platforms META, Tesla TSLA ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

AI models have just taken a startling step toward autonomy. In a shocking experiment, OpenAI’s o3 model rewrote its own code ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

At ICML, the AI research elite gather to present papers, chase jobs, and quietly shape the future of the field.

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

The authors express their deepest appreciation to the Google DeepMind Robotics team and in particular David B. D’Ambrosio, Saminda Abeyruwan, Laura Graesser, Atil Iscen, Alex Bewley and Krista Reymann ...